![John Renger](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Renger
Chief Tech/Sci/R&D Officer at
CEREVEL THERAPEUTICS HOLDINGS, INC.
Profile
Presently, John Renger is Chief Scientific Officer of Cerevel Therapeutics Holdings, Inc. In the past Dr. Renger was Associate Vice President at Merck & Co., Inc. and Vice President-Research & Development at Imbrium Therapeutics LP. He received a doctorate and an undergraduate degree from the University of Iowa.
John Renger active positions
| Companies | Position | Start |
|---|---|---|
| CEREVEL THERAPEUTICS HOLDINGS, INC. | Chief Tech/Sci/R&D Officer | 01/05/2019 |
Former positions of John Renger
| Companies | Position | End |
|---|---|---|
Purdue Pharma LP
 Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Corporate Officer/Principal | 01/04/2018 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/08/2016 |
Imbrium Therapeutics LP
 Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Chief Tech/Sci/R&D Officer | - |
Training of John Renger
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
87
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Medical DistributorsDistribution Services Distributes medicines | Distribution Services |
University of Iowa
 University of Iowa Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Imbrium Therapeutics LP
Imbrium Therapeutics LP Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company | Health Technology |
Cerevel Therapeutics Holdings, Inc.
 Cerevel Therapeutics Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops novel therapies for neurological and psychiatric disorders | Health Technology |
- Stock Market
- Insiders
- John Renger
